ChartMill assigns a fundamental rating of 3 / 10 to SGYP.
ChartMill assigns a valuation rating of 0 / 10 to SYNERGY PHARMACEUTICALS DEL (SGYP). This can be considered as Overvalued.
SYNERGY PHARMACEUTICALS DEL (SGYP) has a profitability rating of 4 / 10.
The dividend rating of SYNERGY PHARMACEUTICALS DEL (SGYP) is 0 / 10 and the dividend payout ratio is 0%.